Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Collins Helen Louise
CHIEF MEDICAL OFFICER at Enliven Therapeutics. Filing since 11 Apr 2024.
CIK 0001701247
Company
Date
Role
Action
Shares
Amount
Of holding
ELVN
Enliven Therapeutics, Inc.
17 Sep 2026
CHIEF MEDICAL OFFICER
Sold on a plan
5,000
$251.75K
16.7%
ELVN
Enliven Therapeutics, Inc.
17 Aug 2026
CHIEF MEDICAL OFFICER
Sold on a plan
5,000
$292.93K
16.7%
ELVN
Enliven Therapeutics, Inc.
17 Jul 2026
CHIEF MEDICAL OFFICER
Sold on a plan
5,000
$263.37K
16.7%
ELVN
Enliven Therapeutics, Inc.
17 Jun 2026
CHIEF MEDICAL OFFICER
Sold on a plan
5,000
$219.02K
16.7%
ELVN
Enliven Therapeutics, Inc.
18 May 2026
CHIEF MEDICAL OFFICER
Sold on a plan
5,000
$198.97K
16.7%
ELVN
Enliven Therapeutics, Inc.
17 Apr 2026
CHIEF MEDICAL OFFICER
Sold on a plan
5,000
$238.35K
16.7%
ELVN
Enliven Therapeutics, Inc.
25 Mar 2026
CHIEF MEDICAL OFFICER
Sold on a plan
40,000
$1.40M
61.5%
ELVN
Enliven Therapeutics, Inc.
17 Mar 2026
CHIEF MEDICAL OFFICER
Sold on a plan
5,000
$138.80K
16.7%
ELVN
Enliven Therapeutics, Inc.
10 Mar 2026
CHIEF MEDICAL OFFICER
Sold on a plan
10,129
$305.83K
28.8%
ELVN
Enliven Therapeutics, Inc.
9 Mar 2026
CHIEF MEDICAL OFFICER
Sold on a plan
29,871
$896.81K
54.4%
ELVN
Enliven Therapeutics, Inc.
17 Feb 2026
CHIEF MEDICAL OFFICER
Sold on a plan
45,000
$1.18M
64.3%
ELVN
Enliven Therapeutics, Inc.
18 Oct 2024
CHIEF MEDICAL OFFICER
Sold on a plan
816
$24.48K
100%
ELVN
Enliven Therapeutics, Inc.
11 Apr 2024
CHIEF MEDICAL OFFICER
Sold on a plan
20,000
$501.48K
100%
13 decisions on file.
